ABCL – abcellera biologics inc. - common shares (US:NASDAQ)
Stock Stats
News
AbCellera Biologics (ABCL) is now covered by JonesTrading. They set a "buy" rating and a $11.00 price target on the stock.
AbCellera (ABCL): Among the Stocks That Could 10x Over the Next 5 Years [Yahoo! Finance]
AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026
CRA: Here's the TFSA Contribution Room for 2026 and Why Now Is the Best Time to Use It [Yahoo! Finance Canada]
AbCellera Biologics Eyes Integrated Biotech Shift; ABCL635 Phase II Data Due in Q3 at Forum [Yahoo! Finance]
Form 4 AbCellera Biologics Inc. For: Feb 27 Filed by: Thermopylae Holdings Ltd.
Form 4 AbCellera Biologics Inc. For: Feb 26 Filed by: Thermopylae Holdings Ltd.
Form 4 AbCellera Biologics Inc. For: Feb 27 Filed by: Booth Andrew
Form S-8 AbCellera Biologics Inc.
Form 10-K AbCellera Biologics Inc. For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.